Interferons (IFNs) are cytokines that produce effects in the CNS even
though their production occurs mainly in the periphery. Direct passage
of IFNs from blood to CNS could be an important route by which circul
ating IFNs exert their central effects. In this report, we characteriz
e the pharmacokinetics of the passage of IFNs through the blood-brain
and blood-spinal cord barriers in four separate regions: whole brain a
nd the cervical, thoracic and lumbosacral segments of the spinal cord.
We found that the spinal cord had greater permeability to IFNs than d
id the brain. For each corresponding region, the permeability to IFN a
lpha was higher than that to IFN gamma. Capillary depletion after card
iac perfusion showed that most of the injected IFN was not entrapped b
y the vasculature but entered the parenchyma of the brain. HPLC showed
that most of the IFN gamma entered in intact form. The passage of rad
ioactively labeled IFN gamma into the brain and cervical spinal cord w
as saturated by a low dose of unlabeled IFN gamma, while passage into
the thoracic and lumbosacral spinal cord was not saturated. In contras
t, for another cytokine, tumor necrosis factor alpha (TNF alpha), a sa
turable transport system was present in distal spinal cord as well as
the brain. The results show that IFNs and TNF alpha can enter the CNS
from the periphery but with regional differences.